340 related articles for article (PubMed ID: 9242259)
1. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
Twitchell W; Brown S; Mackie K
J Neurophysiol; 1997 Jul; 78(1):43-50. PubMed ID: 9242259
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
Guo J; Ikeda SR
Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons.
Shen M; Thayer SA
Brain Res; 1998 Feb; 783(1):77-84. PubMed ID: 9479052
[TBL] [Abstract][Full Text] [Related]
4. Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
Pan X; Ikeda SR; Lewis DL
Mol Pharmacol; 1996 Apr; 49(4):707-14. PubMed ID: 8609900
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.
Gebremedhin D; Lange AR; Campbell WB; Hillard CJ; Harder DR
Am J Physiol; 1999 Jun; 276(6):H2085-93. PubMed ID: 10362691
[TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.
Vásquez C; Navarro-Polanco RA; Huerta M; Trujillo X; Andrade F; Trujillo-Hernández B; Hernández L
Can J Physiol Pharmacol; 2003 May; 81(5):436-42. PubMed ID: 12774849
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
Kim D; Thayer SA
J Neurosci; 2001 May; 21(10):RC146. PubMed ID: 11319244
[TBL] [Abstract][Full Text] [Related]
8. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons.
Fisyunov A; Tsintsadze V; Min R; Burnashev N; Lozovaya N
J Neurophysiol; 2006 Sep; 96(3):1267-77. PubMed ID: 16738209
[TBL] [Abstract][Full Text] [Related]
10. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
11. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
Mackie K; Devane WA; Hille B
Mol Pharmacol; 1993 Sep; 44(3):498-503. PubMed ID: 8371711
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
Huang CC; Lo SW; Hsu KS
J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
[TBL] [Abstract][Full Text] [Related]
13. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
Ameri A; Wilhelm A; Simmet T
Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats.
Khasabova IA; Simone DA; Seybold VS
Neuroscience; 2002; 115(2):613-25. PubMed ID: 12421626
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.
Fan P
J Neurophysiol; 1995 Feb; 73(2):907-10. PubMed ID: 7760148
[TBL] [Abstract][Full Text] [Related]
16. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission.
Hampson AJ; Bornheim LM; Scanziani M; Yost CS; Gray AT; Hansen BM; Leonoudakis DJ; Bickler PE
J Neurochem; 1998 Feb; 70(2):671-6. PubMed ID: 9453561
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.
Pakdeechote P; Dunn WR; Ralevic V
Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons.
Nogueron MI; Porgilsson B; Schneider WE; Stucky CL; Hillard CJ
J Neurochem; 2001 Oct; 79(2):371-81. PubMed ID: 11677265
[TBL] [Abstract][Full Text] [Related]
19. Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures.
Kim DJ; Thayer SA
Brain Res; 2000 Jan; 852(2):398-405. PubMed ID: 10678767
[TBL] [Abstract][Full Text] [Related]
20. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
